Medicover AB
STO:MCOV B
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Medicover AB
Cash from Operating Activities
Medicover AB
Cash from Operating Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Medicover AB
STO:MCOV B
|
Cash from Operating Activities
€343.7m
|
CAGR 3-Years
26%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
|
Dedicare AB (publ)
STO:DEDI
|
Cash from Operating Activities
kr64.4m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
10%
|
CAGR 10-Years
4%
|
|
|
NGS Group AB
STO:NGS
|
Cash from Operating Activities
-kr10m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
I
|
INIFY Laboratories AB
OSE:INIFY
|
Cash from Operating Activities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Medicover AB
Glance View
Medicover AB, founded in 1995, is a prominent healthcare and diagnostic service provider, chiefly operating across Europe and India. The company, based out of Sweden, has carved a niche by offering a broad range of healthcare services, focusing on accessible and premium quality care. Medicover’s structure is multifaceted—comprising two main divisions: Healthcare Services and Diagnostic Services. Their healthcare division administers preventative and primary care services through outpatient clinics, as well as specialist hospital care, emphasizing a holistic approach to patient care. Meanwhile, the Diagnostic Services division performs a vital role, supplying an extensive array of laboratory and imaging services. This dual-pronged business model ensures a steady stream of revenue, bolstering Medicover’s position in the competitive healthcare landscape. The way Medicover makes money is intricately tied to its wide-reaching network and comprehensive service offerings. Revenues are primarily derived from the fees for healthcare and diagnostic services provided directly to patients and through contracts with insurance companies and corporate clients, who seek Medicover’s expertise in employee health management. In navigating the healthcare sector, Medicover leverages its robust technological infrastructure to optimize service delivery and operational efficiency, ensuring patient satisfaction while maintaining cost-effectiveness. By continuously expanding its geographical footprint and diversifying its service portfolio, Medicover is adept at adapting to evolving market demands, thus securing its long-term financial sustainability and reinforcing its commitment to delivering value-driven healthcare solutions.
See Also
What is Medicover AB's Cash from Operating Activities?
Cash from Operating Activities
343.7m
EUR
Based on the financial report for Dec 31, 2025, Medicover AB's Cash from Operating Activities amounts to 343.7m EUR.
What is Medicover AB's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
17%
Over the last year, the Cash from Operating Activities growth was 31%. The average annual Cash from Operating Activities growth rates for Medicover AB have been 26% over the past three years , 17% over the past five years .